Navigation Links
Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com
Date:7/29/2010

About Winner Medical:

Winner Medical is a leading manufacturer and the largest exporter by volume in the medical dressing industry in China. Headquartered in Shenzhen, the Company has eight wholly owned operating subsidiaries and four joint ventures with over 5,000 employees. The Company engages in the manufacturing, sale, research and development of medical care products, wound care products, home care products and PurCotton(R) products, a non-woven fabric made from 100% natural cotton. The products are sold worldwide, with Europe, the United States, China and Japan serving as the top four markets. The Company currently holds more than sixty patents and patent applications for various products and manufacturing processes and is one of the few Chinese companies licensed by the U.S. Food and Drug Administration (FDA) to ship finished, sterilized products directly to the United States market. To learn more about Winner Medical, please visit Winner Medical's web site at: http://ir.winnermedical.com .

Forward-Looking Statements:

This press release contains certain statements that may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medic
'/>"/>

SOURCE Winner Medical Group Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
2. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
3. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
4. Olympic Winner Xiong Ni, Spokesperson for Endoscopic Medicine -- Chinese Minimally Invasive Advanced Technology Top in the World
5. The Scientist Magazine Recognizes febits HybSelect(TM) Among the Winners of Top 10 Innovations of 2009
6. Bayer Express Your Simple Win Creativity Contest Grand Prize Winners Announced
7. Winner Medical Participates in CMEF 2010, China International Medical Equipment Fair, in Shenzhen
8. Lakeside Behavioral Healthcare Named Winner of First Annual Netsmart Technologies Customer Innovation Award
9. Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock
10. NYU-Poly Professor Among First Winners of BioAccelerate NYC Prize; Project May Move Diagnostic Medicine from the Lab to the Palm of a Hand
11. Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, 2015 /PRNewswire/ ... medical device company that is providing innovative evidence-based solutions ... it has commenced an underwritten public offering of its ... by Nevro and 2,459,175 shares to be sold by ... grant the underwriters a 30-day option to purchase up ...
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies in new orphan drug indications, today announced ... trial of  VAL-083  (dianhydrogalactitol) in patients with refractory ... form of human brain cancer. Results ...
(Date:6/1/2015)... CEFALY Technology , the creators of ... authorized for use prior to the onset of migraine ... trial showing that the Cefaly device returns normal metabolic ... patients, namely the orbitofrontal cortex and rostral cingulate. ... an imaging test of the brain, used a radioactive substance called a ...
Breaking Medicine Technology:Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2
... Clinical Development for the Treatment of ... Opioid Bowel Dysfunction, ... presented positive results this week from Phase,1 and preclinical studies of ... in Las Vegas, Nevada. NKTR-118 is,Nektar,s proprietary oral therapy being studied ...
... physician leading clinical trials, FREEPORT, N.Y., ... in treating facial bruising from injectable cosmetic,treatments ... known for,treating under-eye circles. Pinoxide is ... (BMTd),created by AGI Dermatics and formulated in ...
Cached Medicine Technology:Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 2Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 3Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 4Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 5Promising Results in Treating Facial Bruising From Injectables 2
(Date:6/1/2015)... June 01, 2015 Cambia Health ... today a new, interactive Affordable Care Act (ACA) ... The course, called “Affordable Care Act Expert Series, ... the strategic and consultative insights necessary to effectively ... navigate the impacts of the ACA. , The ...
(Date:6/1/2015)... Note: Dr. Julian is available for interviews today ... A phase III trial funded by the National Institutes ... in situ (DCIS) now have an additional tool for ... B-35/NRG Oncology) looked at more than 3,000 DCIS survivors, ... tamoxifen to those who completed five years of the ...
(Date:6/1/2015)... Orlando, FL (PRWEB) June 01, 2015 More ... in the summer months when school is out and they ... National Dairy Month and America’s dairy farmers and milk companies ... children in need with The Great American Milk Drive. ... and milk provided in the school cafeteria for the bulk ...
(Date:6/1/2015)... June 01, 2015 June 1, 2015 ... clinical journals in the areas of hospital medicine, emergency ... that it has expanded upon its partnership with AgileMD ... Hospital Medicine Practice, in a mobile application format ... , “We are very excited about the June ...
(Date:6/1/2015)... 01, 2015 Hexagon Geospatial is pleased ... a new cloud-based subscription service that provides on-demand access ... , Both ERDAS IMAGINE and GeoMedia ... Online, which offers a subscription model for delivering software ... to be able to quickly and easily access the ...
Breaking Medicine News(10 mins):Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3
... form of brain tumor. In many cases, neurosurgeons are not ... of destroying too much brain tissue in the process. Moreover, ... by which the tumor spreads into surrounding healthy tissue. To ... have remained in the head, almost all glioblastoma patients are ...
... Medicine in St. Louis have obtained new evidence that ... in a gene governing not speech, but a metabolic ... a simple association, the study provides the first evidence ... play a role in causing some people to stutter. ...
... novel protective role dendritic cells play in the pancreas. ... journal Gastroenterology , shows dendritic cells can safeguard ... and inflammation of the pancreas gland. "Our ... are needed in the pancreas for normal, healthy pancreatic ...
... . As the "recycling plant" of the cell, ... the cell chokes on its own waste. Cancer cells, in ... their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) ... of drugs that attacks the proteasome in an unusual way. ...
... of retail medical clinics located in pharmacies and other retail settings ... RAND Corporation study. The determining factors in choosing a ... age, health status, income and proximity to the clinic. No link ... was found. The study was published in the American ...
... , TUESDAY, Nov. 22 (HealthDay News) -- ... infants and could mean the different between life and ... the leading cause of death for children younger than ... Control and Prevention. There,s been a significant decline in ...
Cached Medicine News:Health News:Enhanced treatment of brain tumors 2Health News:Surprising pathway implicated in stuttering 2Health News:Surprising pathway implicated in stuttering 3Health News:Dendritic cells protect against acute pancreatitis 2Health News:Dendritic cells protect against acute pancreatitis 3Health News:New class of drugs for the reversible inhibition of proteasomes 2Health News:New class of drugs for the reversible inhibition of proteasomes 3Health News:Use of retail medical clinics rises 10-fold over 2-year period, study finds 2Health News:Get Rid of Bumpers, Stuffed Animals in Baby's Crib 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: